CoA Therapeutics, Inc. clinical trials
A subsidiary of BridgeBio
The registry lists 1 studies whose lead sponsor is CoA Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 21, 2023.
Registry sponsor names on this page
- CoA Therapeutics, Inc., a BridgeBio company1 study
Something wrong with this grouping? Tell us on the BridgeBio page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All BridgeBio studies →
- A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic AcidemiaTerminatedNCT04836494Phase 1
Sponsor listed in the registry: CoA Therapeutics, Inc., a BridgeBio company